nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—Venous thrombosis—Carboplatin—esophageal cancer	0.0685	0.085	CcSEcCtD
Carboprost Tromethamine—Fluid overload—Carboplatin—esophageal cancer	0.0595	0.0738	CcSEcCtD
Carboprost Tromethamine—Extravasation—Carboplatin—esophageal cancer	0.0424	0.0526	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Carboplatin—esophageal cancer	0.0312	0.0386	CcSEcCtD
Carboprost Tromethamine—Vasospasm—Capecitabine—esophageal cancer	0.0234	0.029	CcSEcCtD
Carboprost Tromethamine—Shivering—Capecitabine—esophageal cancer	0.0215	0.0266	CcSEcCtD
Carboprost Tromethamine—Venous thrombosis—Cisplatin—esophageal cancer	0.0201	0.0249	CcSEcCtD
Carboprost Tromethamine—Fluid overload—Cisplatin—esophageal cancer	0.0174	0.0216	CcSEcCtD
Carboprost Tromethamine—Chest tightness—Capecitabine—esophageal cancer	0.017	0.0211	CcSEcCtD
Carboprost Tromethamine—Venous thrombosis—Capecitabine—esophageal cancer	0.0148	0.0184	CcSEcCtD
Carboprost Tromethamine—Infection—Carboplatin—esophageal cancer	0.0131	0.0163	CcSEcCtD
Carboprost Tromethamine—Respiratory distress—Capecitabine—esophageal cancer	0.0126	0.0156	CcSEcCtD
Carboprost Tromethamine—Extravasation—Cisplatin—esophageal cancer	0.0124	0.0154	CcSEcCtD
Carboprost Tromethamine—Haematemesis—Capecitabine—esophageal cancer	0.0115	0.0143	CcSEcCtD
Carboprost Tromethamine—Pain—Carboplatin—esophageal cancer	0.0113	0.014	CcSEcCtD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—PTGS1—esophageal cancer	0.011	0.0628	CbGpPWpGaD
Carboprost Tromethamine—Hiccups—Cisplatin—esophageal cancer	0.0108	0.0135	CcSEcCtD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—ANXA1—esophageal cancer	0.0108	0.0616	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—PTGS1—esophageal cancer	0.0108	0.0615	CbGpPWpGaD
Carboprost Tromethamine—Tafluprost—PTGS2—esophageal cancer	0.0107	0.594	CrCbGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—ANXA1—esophageal cancer	0.0106	0.0603	CbGpPWpGaD
Carboprost Tromethamine—Wheezing—Cisplatin—esophageal cancer	0.0105	0.0131	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Carboplatin—esophageal cancer	0.0104	0.0129	CcSEcCtD
Carboprost Tromethamine—Injection site pain—Capecitabine—esophageal cancer	0.00979	0.0121	CcSEcCtD
Carboprost Tromethamine—Hypoxia—Methotrexate—esophageal cancer	0.00937	0.0116	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Cisplatin—esophageal cancer	0.00914	0.0113	CcSEcCtD
Carboprost Tromethamine—Chest discomfort—Capecitabine—esophageal cancer	0.00903	0.0112	CcSEcCtD
Carboprost Tromethamine—Haematemesis—Methotrexate—esophageal cancer	0.00857	0.0106	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00813	0.0101	CcSEcCtD
Carboprost Tromethamine—Hiccups—Capecitabine—esophageal cancer	0.00799	0.00992	CcSEcCtD
Carboprost Tromethamine—Dinoprostone—CYP19A1—esophageal cancer	0.00734	0.406	CrCbGaD
Carboprost Tromethamine—Extravasation—Methotrexate—esophageal cancer	0.00682	0.00846	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Capecitabine—esophageal cancer	0.00674	0.00836	CcSEcCtD
Carboprost Tromethamine—Sleep disorder—Capecitabine—esophageal cancer	0.0067	0.00832	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Cisplatin—esophageal cancer	0.00663	0.00822	CcSEcCtD
Carboprost Tromethamine—Eye pain—Capecitabine—esophageal cancer	0.00643	0.00797	CcSEcCtD
Carboprost Tromethamine—Hot flush—Capecitabine—esophageal cancer	0.0062	0.0077	CcSEcCtD
Carboprost Tromethamine—Menopausal symptoms—Capecitabine—esophageal cancer	0.00615	0.00763	CcSEcCtD
Carboprost Tromethamine—Thirst—Capecitabine—esophageal cancer	0.0061	0.00756	CcSEcCtD
Carboprost Tromethamine—Respiratory failure—Methotrexate—esophageal cancer	0.00606	0.00752	CcSEcCtD
Carboprost Tromethamine—Lethargy—Capecitabine—esophageal cancer	0.00592	0.00735	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Capecitabine—esophageal cancer	0.0053	0.00657	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Methotrexate—esophageal cancer	0.0053	0.00657	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Cisplatin—esophageal cancer	0.00508	0.0063	CcSEcCtD
Carboprost Tromethamine—Flushing—Cisplatin—esophageal cancer	0.00505	0.00627	CcSEcCtD
Carboprost Tromethamine—Asthma—Capecitabine—esophageal cancer	0.00502	0.00622	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Capecitabine—esophageal cancer	0.00489	0.00606	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00466	0.00578	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Cisplatin—esophageal cancer	0.00456	0.00565	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Cisplatin—esophageal cancer	0.00447	0.00554	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00446	0.00554	CcSEcCtD
Carboprost Tromethamine—Lethargy—Methotrexate—esophageal cancer	0.00441	0.00547	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Capecitabine—esophageal cancer	0.00435	0.00539	CcSEcCtD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—esophageal cancer	0.00423	0.0241	CbGpPWpGaD
Carboprost Tromethamine—Epistaxis—Capecitabine—esophageal cancer	0.00422	0.00523	CcSEcCtD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—esophageal cancer	0.00414	0.0235	CbGpPWpGaD
Carboprost Tromethamine—Myalgia—Cisplatin—esophageal cancer	0.00404	0.00501	CcSEcCtD
Carboprost Tromethamine—Anxiety—Cisplatin—esophageal cancer	0.00402	0.00499	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00387	0.0048	CcSEcCtD
Carboprost Tromethamine—Infection—Cisplatin—esophageal cancer	0.00384	0.00477	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Cisplatin—esophageal cancer	0.00378	0.00468	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Capecitabine—esophageal cancer	0.00374	0.00464	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00374	0.00464	CcSEcCtD
Carboprost Tromethamine—Asthma—Methotrexate—esophageal cancer	0.00373	0.00463	CcSEcCtD
Carboprost Tromethamine—Flushing—Capecitabine—esophageal cancer	0.00373	0.00462	CcSEcCtD
Carboprost Tromethamine—Chills—Capecitabine—esophageal cancer	0.0036	0.00447	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00353	0.00437	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Cisplatin—esophageal cancer	0.00347	0.00431	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00347	0.0043	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Cisplatin—esophageal cancer	0.00345	0.00428	CcSEcCtD
Carboprost Tromethamine—Back pain—Capecitabine—esophageal cancer	0.00338	0.00419	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Capecitabine—esophageal cancer	0.00336	0.00417	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Methotrexate—esophageal cancer	0.00333	0.00413	CcSEcCtD
Carboprost Tromethamine—Pain—Cisplatin—esophageal cancer	0.00331	0.0041	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Capecitabine—esophageal cancer	0.00329	0.00409	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Methotrexate—esophageal cancer	0.00314	0.0039	CcSEcCtD
Carboprost Tromethamine—Vertigo—Capecitabine—esophageal cancer	0.00314	0.00389	CcSEcCtD
Carboprost Tromethamine—Syncope—Capecitabine—esophageal cancer	0.00313	0.00389	CcSEcCtD
Carboprost Tromethamine—Palpitations—Capecitabine—esophageal cancer	0.00309	0.00383	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Capecitabine—esophageal cancer	0.00307	0.00381	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Cisplatin—esophageal cancer	0.00306	0.00379	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—GNG7—esophageal cancer	0.00306	0.0174	CbGpPWpGaD
Carboprost Tromethamine—Cough—Capecitabine—esophageal cancer	0.00305	0.00378	CcSEcCtD
Carboprost Tromethamine—Hypertension—Capecitabine—esophageal cancer	0.00302	0.00374	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—GNG7—esophageal cancer	0.00299	0.017	CbGpPWpGaD
Carboprost Tromethamine—Myalgia—Capecitabine—esophageal cancer	0.00298	0.00369	CcSEcCtD
Carboprost Tromethamine—Chest pain—Capecitabine—esophageal cancer	0.00298	0.00369	CcSEcCtD
Carboprost Tromethamine—Anxiety—Capecitabine—esophageal cancer	0.00296	0.00368	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Cisplatin—esophageal cancer	0.00285	0.00354	CcSEcCtD
Carboprost Tromethamine—Infection—Capecitabine—esophageal cancer	0.00283	0.00352	CcSEcCtD
Carboprost Tromethamine—Shock—Capecitabine—esophageal cancer	0.00281	0.00348	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Methotrexate—esophageal cancer	0.00279	0.00346	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Capecitabine—esophageal cancer	0.00278	0.00345	CcSEcCtD
Carboprost Tromethamine—Asthenia—Cisplatin—esophageal cancer	0.00278	0.00344	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00276	0.00342	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ADCYAP1—esophageal cancer	0.00275	0.0156	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNG7—esophageal cancer	0.00273	0.0156	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ADCYAP1—esophageal cancer	0.00269	0.0153	CbGpPWpGaD
Carboprost Tromethamine—Chills—Methotrexate—esophageal cancer	0.00268	0.00333	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GNG7—esophageal cancer	0.00268	0.0152	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Cisplatin—esophageal cancer	0.00265	0.00328	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.0026	0.00322	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Capecitabine—esophageal cancer	0.00256	0.00318	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Capecitabine—esophageal cancer	0.00254	0.00315	CcSEcCtD
Carboprost Tromethamine—Back pain—Methotrexate—esophageal cancer	0.00252	0.00312	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—ANXA1—esophageal cancer	0.0025	0.0142	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Cisplatin—esophageal cancer	0.00246	0.00305	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Methotrexate—esophageal cancer	0.00245	0.00304	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—ANXA1—esophageal cancer	0.00245	0.0139	CbGpPWpGaD
Carboprost Tromethamine—Rash—Cisplatin—esophageal cancer	0.00244	0.00303	CcSEcCtD
Carboprost Tromethamine—Pain—Capecitabine—esophageal cancer	0.00244	0.00303	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Cisplatin—esophageal cancer	0.00244	0.00302	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—GHRL—esophageal cancer	0.00237	0.0135	CbGpPWpGaD
Carboprost Tromethamine—Vertigo—Methotrexate—esophageal cancer	0.00234	0.0029	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—GHRL—esophageal cancer	0.00232	0.0132	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Cisplatin—esophageal cancer	0.0023	0.00285	CcSEcCtD
Carboprost Tromethamine—Cough—Methotrexate—esophageal cancer	0.00227	0.00282	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Capecitabine—esophageal cancer	0.00225	0.0028	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—esophageal cancer	0.00224	0.0127	CbGpPWpGaD
Carboprost Tromethamine—Chest pain—Methotrexate—esophageal cancer	0.00221	0.00275	CcSEcCtD
Carboprost Tromethamine—Myalgia—Methotrexate—esophageal cancer	0.00221	0.00275	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—esophageal cancer	0.00219	0.0125	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—esophageal cancer	0.00212	0.0121	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactic shock—Methotrexate—esophageal cancer	0.00212	0.00263	CcSEcCtD
Carboprost Tromethamine—Infection—Methotrexate—esophageal cancer	0.00211	0.00262	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Capecitabine—esophageal cancer	0.0021	0.00261	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—esophageal cancer	0.00208	0.0118	CbGpPWpGaD
Carboprost Tromethamine—Hyperhidrosis—Methotrexate—esophageal cancer	0.00205	0.00255	CcSEcCtD
Carboprost Tromethamine—Asthenia—Capecitabine—esophageal cancer	0.00205	0.00254	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Capecitabine—esophageal cancer	0.00195	0.00242	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00193	0.0024	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Methotrexate—esophageal cancer	0.00191	0.00237	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Methotrexate—esophageal cancer	0.00189	0.00235	CcSEcCtD
Carboprost Tromethamine—Somnolence—Methotrexate—esophageal cancer	0.00189	0.00234	CcSEcCtD
Carboprost Tromethamine—Dizziness—Capecitabine—esophageal cancer	0.00189	0.00234	CcSEcCtD
Carboprost Tromethamine—Pain—Methotrexate—esophageal cancer	0.00182	0.00225	CcSEcCtD
Carboprost Tromethamine—Vomiting—Capecitabine—esophageal cancer	0.00181	0.00225	CcSEcCtD
Carboprost Tromethamine—Rash—Capecitabine—esophageal cancer	0.0018	0.00223	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Capecitabine—esophageal cancer	0.0018	0.00223	CcSEcCtD
Carboprost Tromethamine—Headache—Capecitabine—esophageal cancer	0.00179	0.00222	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.00178	0.0101	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.00175	0.00993	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Capecitabine—esophageal cancer	0.00169	0.0021	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Methotrexate—esophageal cancer	0.00168	0.00208	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.00166	0.00943	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.00162	0.00923	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.00161	0.00918	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.00158	0.00898	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.00157	0.00894	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Methotrexate—esophageal cancer	0.00156	0.00194	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.00155	0.00884	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GNG7—esophageal cancer	0.00154	0.00877	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.00154	0.00875	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Methotrexate—esophageal cancer	0.00152	0.00189	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.00152	0.00865	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GNG7—esophageal cancer	0.00151	0.00858	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Methotrexate—esophageal cancer	0.00145	0.0018	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADCYAP1—esophageal cancer	0.00141	0.00803	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Methotrexate—esophageal cancer	0.0014	0.00174	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADCYAP1—esophageal cancer	0.00138	0.00786	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCL2—esophageal cancer	0.00136	0.00773	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Methotrexate—esophageal cancer	0.00135	0.00167	CcSEcCtD
Carboprost Tromethamine—Rash—Methotrexate—esophageal cancer	0.00134	0.00166	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Methotrexate—esophageal cancer	0.00134	0.00166	CcSEcCtD
Carboprost Tromethamine—Headache—Methotrexate—esophageal cancer	0.00133	0.00165	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCL2—esophageal cancer	0.00133	0.00756	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GDI2—esophageal cancer	0.00129	0.00736	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GDI2—esophageal cancer	0.00127	0.0072	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ANXA1—esophageal cancer	0.00126	0.00718	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Methotrexate—esophageal cancer	0.00126	0.00156	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ANXA1—esophageal cancer	0.00124	0.00703	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—SST—esophageal cancer	0.00123	0.00699	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—SST—esophageal cancer	0.0012	0.00684	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GHRL—esophageal cancer	0.0012	0.00681	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GHRL—esophageal cancer	0.00117	0.00666	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AKAP13—esophageal cancer	0.001	0.0057	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AKAP13—esophageal cancer	0.000981	0.00558	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KMT2D—esophageal cancer	0.000936	0.00532	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PDE4D—esophageal cancer	0.000916	0.00521	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KMT2D—esophageal cancer	0.000916	0.00521	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AKAP13—esophageal cancer	0.00091	0.00517	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PDE4D—esophageal cancer	0.000897	0.0051	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AKAP13—esophageal cancer	0.00089	0.00506	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GNG7—esophageal cancer	0.000871	0.00496	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GNG7—esophageal cancer	0.000853	0.00485	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADCYAP1—esophageal cancer	0.000834	0.00474	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PDE4D—esophageal cancer	0.000832	0.00473	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000816	0.00464	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PDE4D—esophageal cancer	0.000814	0.00463	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GNG7—esophageal cancer	0.000791	0.0045	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GNG7—esophageal cancer	0.000775	0.00441	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL2—esophageal cancer	0.000768	0.00437	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—WWOX—esophageal cancer	0.000763	0.00434	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000752	0.00427	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—WWOX—esophageal cancer	0.000747	0.00425	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FKBP1A—esophageal cancer	0.000725	0.00413	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ANXA1—esophageal cancer	0.000714	0.00406	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FKBP1A—esophageal cancer	0.00071	0.00404	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—WIF1—esophageal cancer	0.000709	0.00403	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000699	0.00397	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCL2—esophageal cancer	0.000697	0.00396	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—SST—esophageal cancer	0.000694	0.00395	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—WIF1—esophageal cancer	0.000694	0.00395	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCL2—esophageal cancer	0.000682	0.00388	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—SST—esophageal cancer	0.00068	0.00387	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GHRL—esophageal cancer	0.000677	0.00385	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GHRL—esophageal cancer	0.000662	0.00377	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CSNK1A1—esophageal cancer	0.000654	0.00372	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ANXA1—esophageal cancer	0.000648	0.00369	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000641	0.00364	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ANXA1—esophageal cancer	0.000634	0.00361	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—SST—esophageal cancer	0.000631	0.00359	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.00062	0.00353	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—SST—esophageal cancer	0.000617	0.00351	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GHRL—esophageal cancer	0.000614	0.00349	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PFN1—esophageal cancer	0.000612	0.00348	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000607	0.00345	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000602	0.00342	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GHRL—esophageal cancer	0.000601	0.00342	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PFN1—esophageal cancer	0.000599	0.00341	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000589	0.00335	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ELMO1—esophageal cancer	0.00055	0.00313	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000539	0.00306	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ELMO1—esophageal cancer	0.000538	0.00306	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKAP13—esophageal cancer	0.000537	0.00306	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000527	0.003	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKAP13—esophageal cancer	0.000526	0.00299	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000496	0.00282	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PDE4D—esophageal cancer	0.000491	0.0028	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000485	0.00276	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PDE4D—esophageal cancer	0.000481	0.00274	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GNG7—esophageal cancer	0.000467	0.00266	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GNG7—esophageal cancer	0.000458	0.0026	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—XIAP—esophageal cancer	0.000438	0.00249	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—XIAP—esophageal cancer	0.000429	0.00244	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CTNNA1—esophageal cancer	0.000414	0.00236	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCL2—esophageal cancer	0.000412	0.00234	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CTNNA1—esophageal cancer	0.000405	0.00231	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCL2—esophageal cancer	0.000403	0.00229	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PSME1—esophageal cancer	0.000385	0.00219	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PSME2—esophageal cancer	0.000385	0.00219	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ANXA1—esophageal cancer	0.000383	0.00218	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PSME2—esophageal cancer	0.000377	0.00214	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PSME1—esophageal cancer	0.000377	0.00214	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ANXA1—esophageal cancer	0.000375	0.00213	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SST—esophageal cancer	0.000372	0.00212	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SST—esophageal cancer	0.000365	0.00207	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GHRL—esophageal cancer	0.000363	0.00206	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOTCH3—esophageal cancer	0.000363	0.00206	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FBXW7—esophageal cancer	0.000357	0.00203	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOTCH3—esophageal cancer	0.000355	0.00202	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GHRL—esophageal cancer	0.000355	0.00202	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FBXW7—esophageal cancer	0.00035	0.00199	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOTCH2—esophageal cancer	0.000326	0.00185	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOTCH2—esophageal cancer	0.000319	0.00181	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TGFBR2—esophageal cancer	0.000289	0.00164	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TGFBR2—esophageal cancer	0.000283	0.00161	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SMAD4—esophageal cancer	0.000273	0.00155	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SMAD4—esophageal cancer	0.000268	0.00152	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HIF1A—esophageal cancer	0.000224	0.00127	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HIF1A—esophageal cancer	0.000219	0.00125	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KDR—esophageal cancer	0.000214	0.00122	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KDR—esophageal cancer	0.000209	0.00119	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOTCH1—esophageal cancer	0.000202	0.00115	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOTCH1—esophageal cancer	0.000197	0.00112	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CREBBP—esophageal cancer	0.000183	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—esophageal cancer	0.00018	0.00102	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CREBBP—esophageal cancer	0.000179	0.00102	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—esophageal cancer	0.000176	0.000999	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000172	0.000976	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000168	0.000955	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOS3—esophageal cancer	0.000164	0.00093	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOS3—esophageal cancer	0.00016	0.000911	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CA—esophageal cancer	0.000156	0.000886	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ERBB2—esophageal cancer	0.000153	0.00087	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000153	0.000867	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ERBB2—esophageal cancer	0.00015	0.000852	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCND1—esophageal cancer	0.000135	0.000769	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCND1—esophageal cancer	0.000132	0.000753	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CDKN1A—esophageal cancer	0.000131	0.000744	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CDKN1A—esophageal cancer	0.000128	0.000728	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EP300—esophageal cancer	0.000124	0.000708	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EP300—esophageal cancer	0.000122	0.000693	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MYC—esophageal cancer	0.000108	0.000617	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MYC—esophageal cancer	0.000106	0.000604	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EGFR—esophageal cancer	0.000106	0.000603	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EGFR—esophageal cancer	0.000104	0.00059	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CA—esophageal cancer	9.21e-05	0.000523	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CA—esophageal cancer	9.01e-05	0.000512	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TP53—esophageal cancer	8.91e-05	0.000506	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TP53—esophageal cancer	8.72e-05	0.000496	CbGpPWpGaD
